Results 91 to 100 of about 87,373,768 (197)

Opioid-use disorder among patients on long-term opioid therapy: impact of final DSM-5 diagnostic criteria on prevalence and correlates

, 2015
Joseph A Boscarino,1 Stuart N Hoffman,1 John J Han2 1Center for Health Research, 2Department of Pain Medicine, Geisinger Clinic, Danville, PA, USAAims: Previously, we estimated the prevalence and risk factors for prescription opioid-use disorder among ...
John Han, Joseph Boscarino, Stuart Hoffman, Hoffman SN, Boscarino JA, Han JJ   +5 more
core   +1 more source

Survey Highlights Differences In Medicaid Coverage For Substance Use Treatment And Opioid Use Disorder Medications

, 2016
The Affordable Care Act requires state Medicaid programs to cover substance use disorder treatment for their Medicaid expansion population but allows states to decide which individual services are reimbursable.
Friedmann, Peter, MD
core   +1 more source

Starting a Prehospital Medication for Opioid Use Disorder Program

Prehospital and Disaster Medicine
AbstractBackground:Over 2.7 million people have an opioid use disorder (OUD). Opioid-related deaths have steadily increased over the last decade. Although emergency department (ED)-based medication for OUD (MOUD) has been successful in initiating treatment for patients, there still is a need for improved access.
David C. Seaberg, Jamie McKinnon, Lyn Haselton, Doug Gallo, Jason Kolb, Mary Moran, Suman Vellanki, Amy Raubenolt, Erin Simon, Nicholas Jouriles   +9 more
openaire   +2 more sources

Partner Engagement in Research on Medications for Opioid Use Disorders: A Rapid Review

The objective of this rapid review is to describe how community, government, and other partners are engaged in research on medications for opioid use disorder (MOUD)
Drishti Mukherjee, Alexander Jeremiah, Terrinieka Powell, Heather Gotham, Terrance Embry, Loveline Phillips, Edicer Ramirez Rivera, Lisa Kim, Hannah Cheng, Jori Wright, Shubhi Sharma, Demi Bajela, Thuy Hanley   +12 more
core   +1 more source

Referral to and engagement in substance use disorder treatment within opioid intervention courts in New York: a qualitative study of implementation barriers and facilitators

Substance Abuse Treatment, Prevention, and Policy
Background People with opioid use disorder (OUD) are frequently in contact with the court system and have markedly higher rates of fatal opioid overdose. Opioid intervention courts (OIC) were developed to address increasing rates of opioid overdose among
Megan A. O’Grady, Katherine S. Elkington, Gail Robson, Ikenna Y. Achebe, Arthur Robin Williams, Alwyn T. Cohall, Renee Cohall, Monica Christofferson, Alejandra Garcia, Kelly S. Ramsey, Pat Lincourt, Susan Tross   +11 more
doaj   +1 more source

Gender differences regarding interest in opioid agonist treatment with hydromorphone: a cross-sectional study of syringe service program participants

Harm Reduction Journal
Background In the United States, only 15–20% of people with opioid use disorder (OUD) receive medications for OUD annually. Injectable opioid agonist treatment with hydromorphone (iOAT-H) is a novel approach that reduces non-prescribed opioid use ...
Vitaliy Lasiychuk, Megan Ghiroli, Teresa López-Castro, Aaron D. Fox   +3 more
doaj   +1 more source

A roadmap for maximizing the use and effectiveness of recovery housing for individuals prescribed medications for opiate use disorders

Frontiers in Public Health
IntroductionSafe and stable housing is increasingly recognized as critical to recovery from alcohol and drug use disorders, but research on the outcomes of residents in recovery from opioid use disorder (OUD), particularly those prescribed medications ...
Amy A. Mericle, Carmen L. Masson, Sarah E. Zemore, Meenakshi S. Subbaraman, Dustin Khebzou, Diane Schmidt, Kwinoja Kapiteni, Leonard A. Jason   +7 more
doaj   +1 more source

Receipt of medications for opioid use disorders among veterans by race/ethnicity and legal involvement: an observational study of electronic health records

Health & Justice
Background The Veterans Health Administration has made strides to improve access to medications for opioid use disorder overall. However, quality improvement methods to assess treatment gaps may not sufficiently detect differences in medication access by
Andrea K. Finlay, Ekaterina Pivovarova, Mengfei Yu, Christine Timko, Ingrid A. Binswanger, David Smelson, Emmeline Taylor, Alex H. S. Harris   +7 more
doaj   +1 more source

Comparative effectiveness of different treatment pathways for opioid use disorder.

, 2020
Question: What is the real-world effectiveness of different treatment pathways for opioid use disorder? Findings: In this comparative effectiveness research study of 40 885 adults with opioid use disorder that compared 6 different treatment pathways,
Wakeman, Sarah, Chaisson, Christine, Ameli, Omid, Crown, William H, McPheeters, Jeffrey Thomas, Azocar, Francisca, Sanghavi, Darshak M, Larochelle, Marc R   +7 more
core   +1 more source

Emerging neuromodulation treatments for opioid and stimulant use disorders

Frontiers in Human Neuroscience
Over the past decade, deaths attributable to opioid and stimulant use have risen dramatically. While the U.S. Food and Drug Administration (FDA) has approved three medications for opioid use disorder, there is currently no FDA-approved treatment for ...
Susanna D. Howard, Liming Qiu, Nathan Hager, Anna Rose Childress, Casey H. Halpern, Katherine W. Scangos, Katherine W. Scangos   +6 more
doaj   +1 more source